GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Croma NV (XAMS:EHCS) » Definitions » Asset Impairment Charge

Croma NV (XAMS:EHCS) Asset Impairment Charge : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Croma NV Asset Impairment Charge?

Croma NV's Asset Impairment Charge for the six months ended in Dec. 2023 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.


Croma NV Asset Impairment Charge Historical Data

The historical data trend for Croma NV's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Croma NV Asset Impairment Charge Chart

Croma NV Annual Data
Trend Dec21 Dec22 Dec23
Asset Impairment Charge
- - -

Croma NV Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Asset Impairment Charge - - - - -

Croma NV Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.


Croma NV Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Croma NV's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Croma NV (XAMS:EHCS) Business Description

Traded in Other Exchanges
Address
c/o ALR Treuhand GmbH Theresienhohe 28, Munich, BY, DEU, 80338
European Healthcare Acquisition Growth Co BV is a special purpose acquisition company aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.

Croma NV (XAMS:EHCS) Headlines

No Headlines